Spoken Alpha
BLFS
BIOLIFE SOLUTIONS INC
Overview
BIOLIFE SOLUTIONS INC is a Healthcare company operating in Medical Instruments & Supplies with a $1.23B market cap.
Most recent reported earnings: Q2 FY2026 (Aug 5, 2026).
20 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-0816 Q&A exchanges
- Q4 FY2025Earnings2026-02-2611 Q&A exchanges
- Q3 FY2025Earnings2025-11-069 Q&A exchanges
- Q2 FY2025Earnings2025-08-0811 Q&A exchanges
- Q1 FY2025Earnings2025-05-0820 Q&A exchanges
- Q4 FY2024Earnings2025-03-0325 Q&A exchanges
- Q3 FY2024Earnings2024-11-1222 Q&A exchanges
- Q1 FY2024Earnings2024-05-0917 Q&A exchanges
- Q4 FY2023Earnings2024-02-2919 Q&A exchanges
- Q3 FY2023Earnings2023-11-0920 Q&A exchanges
- Q2 FY2023Earnings2023-08-0818 Q&A exchanges
- Q1 FY2023Earnings2023-05-1017 Q&A exchanges
- Q4 FY2022Earnings2023-03-1617 Q&A exchanges
- Q3 FY2022Earnings2022-11-0923 Q&A exchanges
- Q2 FY2022Earnings2022-08-0915 Q&A exchanges
- Q1 FY2022Earnings2022-05-0919 Q&A exchanges
- Q4 FY2021Earnings2022-02-2818 Q&A exchanges
- Q3 FY2021Earnings2021-11-1126 Q&A exchanges
- Q2 FY2021Earnings2021-08-1222 Q&A exchanges
- Q1 FY2021Earnings2021-05-1336 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-05EPS— vs $0.00—Rev— vs ——EODHD
- Q1 FY20262026-05-07EPS$0.04 vs $0.02+100.0%Rev$27.5M vs ——EODHD
- Q4 FY20252026-03-11EPS$0.04 vs $-0.00+100.0%Rev$18.8M vs ——EODHD
- Q3 FY20252025-11-05EPS$0.04 vs $-0.01+100.0%Rev$28.1M vs ——EODHD
- Q2 FY20252025-08-06EPS$-0.33 vs $-0.03-100.0%Rev$25.4M vs ——EODHD
- Q1 FY20252025-05-06EPS$0.04 vs $-0.04+100.0%Rev$23.9M vs ——EODHD
- Q4 FY20242025-02-25EPS$-0.02 vs $-0.06+71.8%Rev$-3.4M vs ——EODHD
- Q3 FY20242024-11-11EPS$-0.02 vs $-0.09+80.6%Rev$30.6M vs ——EODHD
- Q2 FY20242024-08-07EPS$-0.50 vs $-0.14-100.0%Rev$19.7M vs ——EODHD
- Q1 FY20242024-05-08EPS$-0.23 vs $-0.28+17.9%Rev$18.4M vs ——EODHD
- Q4 FY20232024-02-28EPS$-0.30 vs $-0.34+11.8%Rev$17.4M vs ——EODHD
- Q3 FY20232023-11-08EPS$-0.30 vs $-0.37+18.9%Rev$23.6M vs ——EODHD
- Q2 FY20232023-08-07EPS$-0.23 vs $-0.20-15.0%Rev$39.5M vs ——EODHD
- Q1 FY20232023-05-09EPS$-0.32 vs $-0.21-52.4%Rev$37.7M vs ——EODHD
- Q4 FY20222023-03-15EPS$-1.15 vs $-0.17-100.0%Rev$44.3M vs ——EODHD
- Q3 FY20222022-11-08EPS$-0.23 vs $-0.17-35.3%Rev$40.7M vs ——EODHD
- Q2 FY20222022-08-08EPS$-0.06 vs $-0.21+71.4%Rev$40.5M vs ——EODHD
- Q1 FY20222022-05-08EPS$-0.17 vs $-0.25+32.0%Rev$36.2M vs ——EODHD
- Q4 FY20212022-02-27EPS$-0.37 vs $-0.17-100.0%Rev$37.3M vs ——EODHD
- Q3 FY20212021-11-10EPS$0.00 vs $-0.09+100.0%Rev$33.8M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-05 | — | $0.00 | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-05-07 | $0.04 | $0.02 | +100.0% | $27.5M | — | — | EODHD |
| Q4 FY2025 | 2026-03-11 | $0.04 | $-0.00 | +100.0% | $18.8M | — | — | EODHD |
| Q3 FY2025 | 2025-11-05 | $0.04 | $-0.01 | +100.0% | $28.1M | — | — | EODHD |
| Q2 FY2025 | 2025-08-06 | $-0.33 | $-0.03 | -100.0% | $25.4M | — | — | EODHD |
| Q1 FY2025 | 2025-05-06 | $0.04 | $-0.04 | +100.0% | $23.9M | — | — | EODHD |
| Q4 FY2024 | 2025-02-25 | $-0.02 | $-0.06 | +71.8% | $-3.4M | — | — | EODHD |
| Q3 FY2024 | 2024-11-11 | $-0.02 | $-0.09 | +80.6% | $30.6M | — | — | EODHD |
| Q2 FY2024 | 2024-08-07 | $-0.50 | $-0.14 | -100.0% | $19.7M | — | — | EODHD |
| Q1 FY2024 | 2024-05-08 | $-0.23 | $-0.28 | +17.9% | $18.4M | — | — | EODHD |
| Q4 FY2023 | 2024-02-28 | $-0.30 | $-0.34 | +11.8% | $17.4M | — | — | EODHD |
| Q3 FY2023 | 2023-11-08 | $-0.30 | $-0.37 | +18.9% | $23.6M | — | — | EODHD |
| Q2 FY2023 | 2023-08-07 | $-0.23 | $-0.20 | -15.0% | $39.5M | — | — | EODHD |
| Q1 FY2023 | 2023-05-09 | $-0.32 | $-0.21 | -52.4% | $37.7M | — | — | EODHD |
| Q4 FY2022 | 2023-03-15 | $-1.15 | $-0.17 | -100.0% | $44.3M | — | — | EODHD |
| Q3 FY2022 | 2022-11-08 | $-0.23 | $-0.17 | -35.3% | $40.7M | — | — | EODHD |
| Q2 FY2022 | 2022-08-08 | $-0.06 | $-0.21 | +71.4% | $40.5M | — | — | EODHD |
| Q1 FY2022 | 2022-05-08 | $-0.17 | $-0.25 | +32.0% | $36.2M | — | — | EODHD |
| Q4 FY2021 | 2022-02-27 | $-0.37 | $-0.17 | -100.0% | $37.3M | — | — | EODHD |
| Q3 FY2021 | 2021-11-10 | $0.00 | $-0.09 | +100.0% | $33.8M | — | — | EODHD |
Source: EODHD. BLFS reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks BLFS's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.88 | $3.42 | -15.9% | -4.3% | -5.8% |
| Q4 FY2026 | $2.74 | $3.29 | -16.7% | +1.9% | -0.5% |
| Q3 FY2026 | $2.60 | $3.27 | -20.6% | -0.7% | -1.7% |
| Q2 FY2026 | $2.79 | $3.34 | -16.6% | +0.1% | +1.2% |
| Q1 FY2025 | $2.96 | $3.42 | -13.5% | +2.8% | +0.7% |
| Q4 FY2025 | $2.86 | $3.33 | -14.1% | +5.3% | +3.0% |
| Q3 FY2025 | $2.96 | $3.59 | -17.6% | -4.2% | -2.4% |
| Q2 FY2025 | $2.73 | $3.59 | -24.0% | +0.8% | -1.2% |
| Q1 FY2024 | $2.68 | $3.65 | -26.5% | +0.7% | +2.4% |
| Q4 FY2024 | $3.04 | $3.51 | -13.4% | +2.0% | -0.6% |
Guidance change history
Sample- Q1 FY2026Lowered2026-04-15
- Q4 FY2026Lowered2026-13-15
- Q3 FY2026Lowered2026-10-15
- Q2 FY2026Lowered2026-07-15
- Q1 FY2025Lowered2025-04-15
- Q4 FY2025Lowered2025-13-15
- Q3 FY2025Lowered2025-10-15
- Q2 FY2025Lowered2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Greef Roderick DeCEO4 mono recorded callsCurrentSample
CEO since 2026 • 2/2 beats (100%) • guidance suspended Q3 FY2026
- Troy WichtermanCFO6 mo18 callsCurrentSample
CFO since 2025 • 2/4 beats (50%) • guidance suspended Q2 FY2026
- Sean WernerChief Technology Officer4 mono recorded callsCurrentSample
OTHER_C_SUITE since 2026 • 1/2 beats (50%) • last call held guidance Q3 FY2026
- Todd BerardChief Marketing Officer5 mono recorded callsCurrentSample
OTHER_C_SUITE since 2026 • 1/2 beats (50%) • last call held guidance Q3 FY2026
- Aby J MathewEVP & Chief Scientific Officer6 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • guidance suspended Q2 FY2026
- Karen A FosterChief Quality and Operations5 mono recorded callsCurrentSample
OTHER since 2026 • 1/2 beats (50%) • last guidance cut Q3 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BLFS.
$ curl https://api.spokenalpha.com/v1/companies/BLFSFAQ
Frequently asked about BLFS
Where can I find BIOLIFE SOLUTIONS INC's (BLFS) earnings call transcripts?
Spoken Alpha indexes BLFS's earnings call transcripts at https://spokenalpha.com/companies/BLFS. Each call links to attributed speakers and parsed analyst Q&A.
When was BIOLIFE SOLUTIONS INC's most recent earnings call?
BIOLIFE SOLUTIONS INC (BLFS) held its most recent earnings call on 2026-05-08, covering fiscal Q1 2026.
What sector is BLFS in?
BIOLIFE SOLUTIONS INC (BLFS) operates in the Healthcare sector (Medical Instruments & Supplies industry).